It was reassuring to see from the safety data that there weren't any signals for more serious adverse events with evolocumab than placebo. Did this trend apply across different levels of achieved LDL-C? For example, the lowest tertile vs. the highest tertile in the treatment group? Have any concerns arisen from observational studies of patients who have loss of function mutations in PCSK9?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.